These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2414167)
1. Lymphoblastic lymphoma in a female with chronic granulocytic leukaemia. Jarczok K; Krawczyk-Kuliś M; Duraj M; Hołowiecki J; Rudzka E Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):391-6. PubMed ID: 2414167 [TBL] [Abstract][Full Text] [Related]
2. Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old. Italiano A; Jardin F; Peyrade F; Saudes L; Tilly H; Thyss A Haematologica; 2005 Sep; 90(9):1281-3. PubMed ID: 16154857 [TBL] [Abstract][Full Text] [Related]
3. Clinical investigations in aggressive non-Hodgkin lymphoma. Jonathan F Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259 [No Abstract] [Full Text] [Related]
4. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma. Simonelli C; Zanussi S; Cinelli R; Dal Maso L; Di Gennaro G; D'Andrea M; Nasti G; Spina M; Vaccher E; De Paoli P; Tirelli U Clin Infect Dis; 2003 Sep; 37(6):820-7. PubMed ID: 12955644 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone. Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771 [TBL] [Abstract][Full Text] [Related]
7. New concepts in treatment approaches and prognostic factors in aggressive NHL. Shipp M Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917 [No Abstract] [Full Text] [Related]
8. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Spina M; Simonelli C; Tirelli U J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261 [No Abstract] [Full Text] [Related]
9. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467 [TBL] [Abstract][Full Text] [Related]
10. Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia. Robak E; Góra-Tybor J; Kordek R; Wawrzyniak E; Bartkowiak J; Bednarek A; Constantinou M; Kałuzewski B; Robak T Br J Dermatol; 2005 Oct; 153(4):833-7. PubMed ID: 16181471 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage. Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285 [TBL] [Abstract][Full Text] [Related]
13. [Lymphoproliferative disease following kidney transplantation]. Merkle M; Rupprecht HD Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1691-4. PubMed ID: 16003604 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737 [TBL] [Abstract][Full Text] [Related]
15. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma. Shabbat S; Aharoni J; Sarid L; Ben-Harush M; Kapelushnik J Pediatr Blood Cancer; 2009 May; 52(5):664-6. PubMed ID: 19142990 [TBL] [Abstract][Full Text] [Related]
16. Primary large B-cell lymphoma of the bone marrow. Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843 [No Abstract] [Full Text] [Related]
17. Some problems in the management of leukaemia and lymphoma. Galton DA Proc R Soc Med; 1966 Dec; 59(12):1268-72. PubMed ID: 5225194 [No Abstract] [Full Text] [Related]
19. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. Alliot C J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060 [No Abstract] [Full Text] [Related]
20. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy. Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]